NIHR i4i and Innovate UK’s first Angels in Medcity Entrepreneur Pitching Event
NIHR’s Invention for Innovation (i4i) Programme has held its first entrepreneur pitching event, in collaboration with Innovate UK – bringing together medical technology start-ups and giving them the chance to pitch to a community of business angels interested in life science and medical technologies.
Martin Hunt, i4i Programme Director, said, “The event represented an excellent opportunity for NIHR i4i and Innovate UK to showcase the superb quality of technological innovation and entrepreneurial expertise in the UK life sciences and medtech space the two funders support.”
The i4i Programme invests in disruptive early-stage medtech technologies to accelerate the translation of innovation into the NHS and the wider market for increased patient benefit. The programme supports collaborative projects that involve SMEs, universities and the NHS, with strong management teams and a clear commercial pathway towards adoption. The aim of i4i is to de-risk technologies to make them attractive to follow-on funders and private investors. The i4i-funded companies at the event proposed cutting-edge solutions to a range of important unmet clinical needs.
CORTIRIO are pioneering the development of portable scanners to be used at the point of care for rapid diagnosis and monitoring of traumatic brain injuries.
Patrick Beldon, CORTIRIO CEO said, “Having the NIHR and Innovate UK working together is helping to support companies from different angles. Having access to investors who have a particular interest in medical companies is great because we know we’re pitching to the right people who have expertise that can help us out along the way.”
NEPeSMO®, a start-up which spun-out from University Hospitals of North Midlands, is developing self-monitoring, personalised products and services to predict and prevent lung attacks in patients with chronic respiratory conditions.
Professor Monica Spiteri, NEPeSMO® Co-Founder and Chief Operating Officer, said “The evening itself provided a lot of interaction and invaluable networking.”
For i4i this could be the first in a proposed series of similar events leveraging NIHR’s investment and boosting the chances of promising technology attracting follow-on funding and ultimately leading to benefits for patients.
Martin Hunt said, “NIHR i4i and Innovate UK are key funders in the medtech landscape. The collaboration demonstrates the joint commitment to funding breakthrough innovations that will benefit patients and to supporting the SME sector, crucial in boosting productivity and the UK plc growth.”